New Zealand · Delayed Price · Currency is NZD Synlait Milk Earnings Call Transcripts
Fiscal Year 2026
-
Half-year results showed a significant net loss and increased debt, driven by manufacturing disruptions and weak ingredient prices. The upcoming North Island asset sale is expected to reduce debt and simplify operations, while strong growth continues in Consumer and Foodservice segments.
Fiscal Year 2025
-
The meeting focused on financial recovery, with approval sought for the sale of North Island assets to reduce debt and reset strategy. Board structure changes, operational improvements, and diversification plans were discussed, with strong shareholder support for all resolutions.
-
FY 2025 saw a return to profitability, record revenue, and a major asset sale to Abbott, positioning the company for a debt-free future and a strategic focus on South Island operations. Operational stability and a strategic reset are key priorities for FY 2026.
-
Profitability returned with NPAT of $4.8M and EBITDA of $63.1M, as revenue rose 16% to $916.8M. Net debt fell 29% to $392M, driven by strong advanced nutrition growth and cost control. Outlook remains positive, though second-half progress will be slower due to FX and milk stream risks.
Fiscal Year 2024
-
The meeting addressed a challenging FY 2024 with a significant loss, a major balance sheet reset, and strategic focus on milk supply, operational performance, and sustainability. Board and auditor changes were discussed, and all resolutions were put to vote, with results to be published.
-
FY24 saw significant losses and margin pressures due to weak demand, high debt, and operational challenges, but a major equity raise and refinancing have reset the balance sheet. Dairyworks delivered record results, while Advanced Nutrition and Ingredients faced headwinds. No FY25 guidance was issued as recovery efforts continue.